ADO 0.00% 2.2¢ anteotech ltd

why ADO is a multi multi bagger, page-1767

  1. 4,317 Posts.
    lightbulb Created with Sketch. 13061
    with this Australian biosecurity partnership. remember when ross vasta visited ADO headquarters and gave this speech in parliament.


    https://rossvasta.com.au/2023/03/20/constituency-statements-anteotech/

    "Both areas are key to securing Australia’s future.

    The life science team at AnteoTech have developed AnteoBind. AnteoBind is a unique and powerful solution that makes point-of-care testing and diagnosis more effective, efficient and, more importantly, accurate.

    Not only can AnteoBind be used to test for diseases like COVID-19, it has the potential to be used for testing in other areas, such as the agricultural industry, which is worth over $71 billion to our economy.

    Foot-and-mouth disease in Indonesia still poses a very real and very current threat to the Australian livestock industry.

    Whilst we can be thankful for our strong biosecurity measures that have so far kept this disease from re-entering Australia, we cannot become complacent.

    Imagine having a point-of-care test at the airport, ready to use for returning Australians and for incoming tourists.

    A point-of-care test for foot-and-mouth disease would help prevent this disease from re-entering our country, which would devastate our livestock industry and would endanger our food security."


    could it have been just a random thought from ross or maybe a hint was given to him?

    ps. think I know, who to nominate for a new board position. they have all the answers....
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.000(0.00%)
Mkt cap ! $54.31M
Open High Low Value Volume
2.2¢ 2.2¢ 2.1¢ $734 33.69K

Buyers (Bids)

No. Vol. Price($)
2 678087 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 174064 2
View Market Depth
Last trade - 16.10pm 10/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.